Rigel Pharmaceuticals (RIGL) Short term Debt (2023 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Short term Debt came in at $29.9 million in Q1 2026, up 101.59% year-on-year from $14.8 million in Q1 2025, and little changed quarter-over-quarter from $29.8 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Short term Debt (2023 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Short term Debt history runs 4 years deep, the most recent figure standing at $29.9 million for Q1 2026.
- On a quarterly basis, Short term Debt rose 101.59% year-over-year to $29.9 million in Q1 2026; TTM through Mar 2026 was $29.9 million, a 101.59% increase from a year earlier, with the FY2025 full-year figure at $29.8 million, up 309.96% from the prior year.
- Short term Debt steadied at $29.9 million in Q1 2026 per RIGL's latest filing, from $29.8 million in the prior quarter.
- Across five years, Short term Debt topped out at $29.9 million in Q1 2026 and bottomed at $7.2 million in Q4 2023.
- The 4-year median for Short term Debt is $18.6 million (2025), against an average of $19.5 million.
- Biggest YoY gain for Short term Debt was 309.96% in 2025; the steepest drop was 0.24% in 2025.
- Year by year, Short term Debt stood at $7.2 million in 2023, then climbed by 0.59% to $7.3 million in 2024, then jumped by 309.96% to $29.8 million in 2025, then climbed by 0.18% to $29.9 million in 2026.
- Per Business Quant, the three latest RIGL Short term Debt figures stand at $29.9 million (Q1 2026), $29.8 million (Q4 2025), and $29.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.87 Mn |
| Dec 31, 2025 | 29.81 Mn |
| Sep 30, 2025 | 29.76 Mn |
| Jun 30, 2025 | 22.36 Mn |
| Mar 31, 2025 | 14.82 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Mar 31, 2024 | 14.78 Mn |
| Dec 31, 2023 | 7.23 Mn |